Tenofovir Exalidex

N/A

Report date: 2023/06/16 20:00:33

Base Information

Drug NameTenofovir Exalidex
Drug Alias NameHDP-TenofovirLipid conjugate YTFVHexadecyloxypropyl-tenofovirLipid conjugate TFV (tenofovir)TXL +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsRenal InsufficiencyCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChimerix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencyCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A